Real-World Effectiveness of Adjuvant Oxaliplatin Chemotherapy in Stage III Colon Cancer: A Controlled Interrupted Time Series Analysis
Background: The real-world effectiveness of oxaliplatin in stage III colon cancer has not been determined in a large-scale population. We aimed to assess the real-world impact of adjuvant oxaliplatin treatment on the survival of these patients.Methods: Based on Taiwan cancer registry, we evaluated 1...
Main Authors: | Wen-Kuan Huang, Hung-Chih Hsu, Shu-Hao Chang, Wen-Chi Chou, Pei-Hung Chang, Sum-Fu Chiang, John Wen-Cheng Chang, Jen-Shi Chen, Tsai-Sheng Yang, Lai-Chu See |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.693009/full |
Similar Items
-
Modified biweekly oxaliplatin and capecitabine for advanced gastric cancer: A retrospective analysis from a medical center
by: Yung-Chia Kuo, et al.
Published: (2014-06-01) -
Characteristics and Risk Factors of Oxaliplatin-related Hypersensitivity Reactions
by: Yu-Yun Shao, et al.
Published: (2010-05-01) -
Tumor lysis syndrome in a patient with metastatic colon cancer after treatment with oxaliplatin and 5-Fu
by: Ruo-Han Tseng, et al.
Published: (2016-12-01) -
Oxaliplatin-Associated Amaurosis Fugax
by: Kimitoshi Kubo, et al.
Published: (2021-06-01) -
Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
by: Guoxiu Wang, et al.
Published: (2018-05-01)